首页> 中文期刊> 《中外医疗》 >泻痢康胶囊治疗艾滋病相关慢性腹泻的临床研究

泻痢康胶囊治疗艾滋病相关慢性腹泻的临床研究

         

摘要

Objective Xie Li Kang Capsule treatment of AIDS-related clinical effects of chronic diarrhea research and analysis. Methods April 2012 to April 2014 in our hospital treated 100 cases of AIDS-related clinical studies in patients with chronic di-arrhea, were randomly divided into two groups, control and study groups were using loperamide hydrochloride capsules Xie Li Kang capsules for treatment, comparing the two groups. Results The study group therapy to reduce the amount of stool in patients with≥50%of patients was significantly higher than the control group (P<0.05);treatment one week and two weeks after the stool frequency study group was significantly lower than the control group (P<0.05). After two weeks of treatment in patients with diar-rhea in the study group were significantly lower scale scores (P<0.05). Cases of adverse reactions between the two groups was not obvious (P>0.05). Conclusion Xie Li Kang Capsule treatment-related chronic diarrhea in patients with AIDS clinical better, can significantly improve symptoms, side effects.%目的:对泻痢康胶囊治疗艾滋病相关慢性腹泻的临床效果进行研究分析。方法对2012年4月-2014年4月期间在该院接受治疗的100例艾滋病相关慢性腹泻患者进行临床研究,随机分为两组,对照组和研究组分别使用盐酸洛哌丁胺胶囊和泻痢康胶囊进行治疗,比较两组疗效。结果研究组治疗后患者的大便总量减少≥50%的例数明显比对照组高(P<0.05);治疗1周和2周后研究组的大便次数也明显低于对照组(P<0.05)。治疗2周后研究组患者的腹泻量表分值明显低于对照组(P<0.05)。两组出现不良反应的情况差异无统计学意义(P>0.05)。结论使用泻痢康胶囊治疗艾滋病相关慢性腹泻患者的临床效果较好,可明显改善患者的症状,不良反应小。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号